Tokyo, Feb. 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060637) titled 'An observational study to evaluate the efficacy and safety of endoscopic treatment for non-ampullary duodenal tumors' on Feb. 10.
Study Type:
Observational
Primary Sponsor:
Institute - Yokohama City University
Condition:
Condition - Patients who underwent endoscopic treatment for duodenal tumors at our institution between April 2011 and March 2027
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - o evaluate the efficacy and safety of endoscopic treatment in patients with duodenal tumors.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients diagnosed with duodenal tumors
Patients who underwent endoscopic resection
Patients aged 18 years or older at the time of endoscopic treatment
No restriction on sex
Key exclusion criteria - Patients who opted out of participation (i.e., requested not to be included in the study).
Target Size - 200
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2024 Year 02 Month 16 Day
Date of IRB - 2024 Year 03 Month 16 Day
Anticipated trial start date - 2025 Year 04 Month 01 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069354
Disclaimer: Curated by HT Syndication.
